- Poster presentation
- Open Access
Endothelial glycocalyx disruption after cardiac surgery in infants
Critical Care volume 15, Article number: P82 (2011)
The endothelial glycocalyx (EGX) modulates vascular permeability and inflammation. It is disrupted by ischaemia-reperfusion. We hypothesised that cardiopulmonary bypass would elevate markers of EGX shedding, which would be associated with increased postoperative inflammation.
A prospective cohort of 25 infants (median weight 5 kg) undergoing surgery for congenital heart disease. Blood temporal pro-files of two markers of EGX disruption - heparan sulphate (HEP) and syndecan-1 (SYND) - were correlated with a biochemical marker of systemic inflammation (IL-6) and clinical outcome variables.
Infants showed a dramatic rise in SYND, which peaked at the end of bypass, returning to baseline at 48 hours (Figure 1). The median (IQR) peak SYND levels were 144 ng/ml (113 to 190), representing a sixfold rise from baseline. A less pronounced rise was seen for HEP (median 22.5 μg/ml), which approximately doubled. Peak IL-6 occurred at 12 hours post bypass: median 118 pg/ml (44 to 217). Absolute peak values of both SYND and HEP correlated poorly with IL-6 and all clinical variables. Conversely, peak IL-6 correlated with bypass time (r = 0.53), length of ventilation (r = 0.69) and ICU stay (r = 0.58).
Although markers of EGX disruption show a reproducible temporal profile after bypass, the lack of correlation with IL-6 and clinical markers means that their significance is unclear.
About this article
Cite this article
Sheward, V., Tibby, S., Bangalore, H. et al. Endothelial glycocalyx disruption after cardiac surgery in infants. Crit Care 15, P82 (2011). https://doi.org/10.1186/cc9502
- Congenital Heart Disease
- Congenital Heart
- Cardiopulmonary Bypass
- Systemic Inflammation
- Biochemical Marker